The Drug Screening Market was valued at USD 7.6 billion in 2023 and is forecasted to experience substantial growth, reaching USD 29.7 billion by 2032 at an impressive CAGR of 16.3% during the forecast period 2024-2032. The rising prevalence of substance abuse, increasing workplace safety initiatives, and stringent regulatory mandates are driving the global market’s rapid expansion.Key Growth Dri..